Montefiore Medical Center-Montefiore Medical Park — The Bronx, New York

Montefiore Medical Center-Montefiore Medical Park is a clinical research site located in The Bronx, New York, United States 10461.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

Montefiore Medical Center-Montefiore Medical Park has participated in 13 clinical trials with 12 currently active.

Therapeutic areas: mCRPC, Triple Negative Breast Cancer, PD-L1 Positive.

Sponsors: Pfizer, Gilead Sciences, Deciphera Pharmaceuticals, LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in The Bronx

Browse all research sites in New York · View every site in The Bronx

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Montefiore Medical Center-Montefiore Medical Park?

Montefiore Medical Center-Montefiore Medical Park has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Montefiore Medical Center-Montefiore Medical Park conducted?

Montefiore Medical Center-Montefiore Medical Park has 13 clinical trials on record, with 12 currently active. Their work covers mCRPC, Triple Negative Breast Cancer, PD-L1 Positive.

Is Montefiore Medical Center-Montefiore Medical Park accredited by Crixeo Clinical Trials?

Montefiore Medical Center-Montefiore Medical Park has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Montefiore Medical Center-Montefiore Medical Park?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.